Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss ... use after trial data showed it to be far more potent than another popular GLP-1 agent ...

Net Income was $75.6 million, up from a loss of $7.6 million in the ... The international rollout of its MindBody GLP-1 system will begin in March 2025. Before you make your next trade, you ...

However, after starting on a GLP-1, Winfrey said she came to believe ... “I had an awareness of [weight loss] medications [before], but felt I had to prove I had the willpower to do it.

Related FDA approves weight-loss drug Zepbound to treat sleep apnea FDA says shortage of GLP-1 drug tirzepatide is ... colleagues found that these sought-after medications "have broad health ...

However, Clinic Secret has emerged as a potential game-changer in weight loss by offering a clinically proven, accessible solution that leverages the power of GLP-1 medications. In this ...

But GLP-1 users may have to stay on them long-term to maintain their weight loss. Side effects and high costs pose barriers to long-term use, he said. And studies show that people who go off their ...